Both the protein and mRNA expression of CERS2 were downregulated in advanced bladder cancer tissues and they were significantly associated with tumor stage, the depth of tumor invasion, and tumor recurrence. The gene discussed is CERS2; the disease is urinary bladder carcinoma.